Literature DB >> 29352420

Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.

Debra Guss1, Jagannath Sherigar2, Paul Rosen3, Smruti R Mohanty2.   

Abstract

Hepatitis C virus (HCV) infection is a significant health problem worldwide, and is the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation in the United States. The management of HCV has changed significantly over the last 5 years, as treatments have become simpler and more efficacious. Medication efficacy is now greater than 90%, with a high barrier to resistance and few side effects. This review is a collaboration between primary care and hepatology providers to explore all aspects of HCV management: acute versus chronic HCV infection, transmission and testing, and diagnosis and treatment. Specific medications for the treatment of HCV infection are considered, and patient and medication factors including genotype, liver disease status, and comorbidities affecting medication choice are discussed. This is a new era for the management of HCV infection, and interested primary care physicians, family doctors, and general internists can be at the forefront of diagnosis, management, and treatment of HCV.

Entities:  

Keywords:  direct-acting antivirals (DAA); hepatitis C; primary care management

Mesh:

Substances:

Year:  2018        PMID: 29352420      PMCID: PMC5880771          DOI: 10.1007/s11606-017-4280-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  41 in total

1.  Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned.

Authors:  David J Back; David M Burger
Journal:  Gastroenterology       Date:  2015-09-28       Impact factor: 22.682

Review 2.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

Review 3.  Natural history of hepatitis C.

Authors:  Rachel H Westbrook; Geoffrey Dusheiko
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

4.  Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

Authors:  Andrea L Cox; Dale M Netski; Timothy Mosbruger; Susan G Sherman; Steffanie Strathdee; Danielle Ompad; David Vlahov; David Chien; Venkatakrishna Shyamala; Stuart C Ray; David L Thomas
Journal:  Clin Infect Dis       Date:  2005-03-03       Impact factor: 9.079

5.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

6.  Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Authors:  Paul Y Kwo; Eric J Lawitz; Jonathan McCone; Eugene R Schiff; John M Vierling; David Pound; Mitchell N Davis; Joseph S Galati; Stuart C Gordon; Natarajan Ravendhran; Lorenzo Rossaro; Frank H Anderson; Ira M Jacobson; Raymond Rubin; Kenneth Koury; Lisa D Pedicone; Clifford A Brass; Eirum Chaudhri; Janice K Albrecht
Journal:  Lancet       Date:  2010-08-06       Impact factor: 79.321

7.  Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.

Authors:  Kris V Kowdley; Stuart C Gordon; K Rajender Reddy; Lorenzo Rossaro; David E Bernstein; Eric Lawitz; Mitchell L Shiffman; Eugene Schiff; Reem Ghalib; Michael Ryan; Vinod Rustgi; Mario Chojkier; Robert Herring; Adrian M Di Bisceglie; Paul J Pockros; G Mani Subramanian; Di An; Evguenia Svarovskaia; Robert H Hyland; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; David Pound; Michael W Fried
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 9.  Non-invasive assessment of liver fibrosis.

Authors:  Vasilios Papastergiou; Emmanuel Tsochatzis; Andrew K Burroughs
Journal:  Ann Gastroenterol       Date:  2012

10.  Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.

Authors:  Jagannath M Sherigar; Vijay Gayam; Arifa Khan; Osama Mukhtar; Yavgeniy Arefiev; Mazin Khalid; Imran Siddiqui; Ayyappa M Rangaraju; Nibash Budhathoki; Mohammed Mansour; Debra Guss; Smruti R Mohanty
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-07       Impact factor: 2.566

View more
  6 in total

1.  HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.

Authors:  Sabrina A Assoumou; Jianing Wang; Shayla Nolen; Golnaz Eftekhari Yazdi; Kenneth H Mayer; Jon Puro; Joshua A Salomon; Benjamin P Linas
Journal:  J Gen Intern Med       Date:  2020-03-04       Impact factor: 5.128

Review 2.  Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.

Authors:  Allison E Wang; Eric Hsieh; Barbara J Turner; Norah Terrault
Journal:  J Gen Intern Med       Date:  2022-04-28       Impact factor: 6.473

3.  Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals.

Authors:  Julia L Marcus; Michael J Silverberg; Jennifer O Lam; Leo B Hurley; Jennifer B Lai; Varun Saxena; Suk Seo; Scott Chamberland; Charles P Quesenberry; Jamila H Champsi; Joanna Ready; Elizabeth Y Chiao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-28       Impact factor: 4.090

4.  There's just not enough time: a mixed methods pilot study of hepatitis C virus screening among baby boomers in primary care.

Authors:  Monica L Kasting; Julie Rathwell; Kaitlyn M Gabhart; Jennifer Garcia; Richard G Roetzheim; Olveen Carrasquillo; Anna R Giuliano; Susan T Vadaparampil
Journal:  BMC Fam Pract       Date:  2020-12-02       Impact factor: 2.497

5.  Prevalence of HCV Infection Among Hemodialysis Patients in Lanzhou of Northwestern China.

Authors:  Kai Bao; Jijun Chen; Ruifang Liu; Yuanyuan Xiang; Wenlong Gao
Journal:  Infect Drug Resist       Date:  2022-09-22       Impact factor: 4.177

6.  Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region.

Authors:  Jacqueline E Sherbuk; Terry Kemp Knick; Chelsea Canan; Patrice Ross; Bailey Helbert; Eleanor Sue Cantrell; Charlene Joie Cantrell; Rachel Stallings; Nicole Barron; Diana Jordan; Kathleen A McManus; Rebecca Dillingham
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.